189 related articles for article (PubMed ID: 16979119)
1. Inhibition of IL-8 release from CFTR-deficient lung epithelial cells following pre-treatment with fenretinide.
Vilela RM; Lands LC; Meehan B; Kubow S
Int Immunopharmacol; 2006 Nov; 6(11):1651-64. PubMed ID: 16979119
[TBL] [Abstract][Full Text] [Related]
2. Ibuprofen modulates NF-kB activity but not IL-8 production in cystic fibrosis respiratory epithelial cells.
Dauletbaev N; Lam J; Eklove D; Iskandar M; Lands LC
Respiration; 2010; 79(3):234-42. PubMed ID: 19887769
[TBL] [Abstract][Full Text] [Related]
3. High hydrostatic pressure enhances whey protein digestibility to generate whey peptides that improve glutathione status in CFTR-deficient lung epithelial cells.
Vilela RM; Lands LC; Chan HM; Azadi B; Kubow S
Mol Nutr Food Res; 2006 Nov; 50(11):1013-29. PubMed ID: 17054101
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory effect of sodium 4-phenylbutyrate in deltaF508-cystic fibrosis transmembrane conductance regulator lung epithelial cells: involvement of extracellular signal-regulated protein kinase 1/2 and c-Jun-NH2-terminal kinase signaling.
Roque T; Boncoeur E; Saint-Criq V; Bonvin E; Clement A; Tabary O; Jacquot J
J Pharmacol Exp Ther; 2008 Sep; 326(3):949-56. PubMed ID: 18574003
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by TNF-alpha and IL-4 of cationic lipid mediated gene transfer in cystic fibrosis tracheal gland cells.
Bastonero S; Gargouri M; Ortiou S; Guéant JL; Merten MD
J Gene Med; 2005 Nov; 7(11):1439-49. PubMed ID: 16001392
[TBL] [Abstract][Full Text] [Related]
6. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis.
Guilbault C; De Sanctis JB; Wojewodka G; Saeed Z; Lachance C; Skinner TA; Vilela RM; Kubow S; Lands LC; Hajduch M; Matouk E; Radzioch D
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):47-56. PubMed ID: 17656682
[TBL] [Abstract][Full Text] [Related]
7. Enhanced IL-1beta-induced IL-8 production in cystic fibrosis lung epithelial cells is dependent of both mitogen-activated protein kinases and NF-kappaB signaling.
Muselet-Charlier C; Roque T; Boncoeur E; Chadelat K; Clement A; Jacquot J; Tabary O
Biochem Biophys Res Commun; 2007 Jun; 357(2):402-7. PubMed ID: 17420005
[TBL] [Abstract][Full Text] [Related]
8. CFTR mediates apoptotic volume decrease and cell death by controlling glutathione efflux and ROS production in cultured mice proximal tubules.
l'Hoste S; Chargui A; Belfodil R; Corcelle E; Duranton C; Rubera I; Poujeol C; Mograbi B; Tauc M; Poujeol P
Am J Physiol Renal Physiol; 2010 Feb; 298(2):F435-53. PubMed ID: 19906953
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-alpha and respiratory syncytial virus stimulation.
Black HR; Yankaskas JR; Johnson LG; Noah TL
Am J Respir Cell Mol Biol; 1998 Aug; 19(2):210-5. PubMed ID: 9698592
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effect of miglustat in bronchial epithelial cells.
Dechecchi MC; Nicolis E; Norez C; Bezzerri V; Borgatti M; Mancini I; Rizzotti P; Ribeiro CM; Gambari R; Becq F; Cabrini G
J Cyst Fibros; 2008 Nov; 7(6):555-65. PubMed ID: 18815075
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells.
Cigana C; Assael BM; Melotti P
Antimicrob Agents Chemother; 2007 Mar; 51(3):975-81. PubMed ID: 17210769
[TBL] [Abstract][Full Text] [Related]
12. Calcium-dependent regulation of NF-(kappa)B activation in cystic fibrosis airway epithelial cells.
Tabary O; Boncoeur E; de Martin R; Pepperkok R; Clément A; Schultz C; Jacquot J
Cell Signal; 2006 May; 18(5):652-60. PubMed ID: 16084692
[TBL] [Abstract][Full Text] [Related]
13. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways.
Verhaeghe C; Remouchamps C; Hennuy B; Vanderplasschen A; Chariot A; Tabruyn SP; Oury C; Bours V
Biochem Pharmacol; 2007 Jun; 73(12):1982-94. PubMed ID: 17466952
[TBL] [Abstract][Full Text] [Related]
14. Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells.
Venkatakrishnan A; Stecenko AA; King G; Blackwell TR; Brigham KL; Christman JW; Blackwell TS
Am J Respir Cell Mol Biol; 2000 Sep; 23(3):396-403. PubMed ID: 10970832
[TBL] [Abstract][Full Text] [Related]
15. Role of IL-10 deficiency in excessive nuclear factor-kappaB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout mice.
Saadane A; Soltys J; Berger M
J Allergy Clin Immunol; 2005 Feb; 115(2):405-11. PubMed ID: 15696103
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells.
Saint-Criq V; Ruffin M; Rebeyrol C; Guillot L; Jacquot J; Clement A; Tabary O
Eur J Pharmacol; 2012 Jan; 674(1):1-6. PubMed ID: 22056837
[TBL] [Abstract][Full Text] [Related]
17. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.
Teichgräber V; Ulrich M; Endlich N; Riethmüller J; Wilker B; De Oliveira-Munding CC; van Heeckeren AM; Barr ML; von Kürthy G; Schmid KW; Weller M; Tümmler B; Lang F; Grassme H; Döring G; Gulbins E
Nat Med; 2008 Apr; 14(4):382-91. PubMed ID: 18376404
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis transmembrane regulator inhibitors CFTR(inh)-172 and GlyH-101 target mitochondrial functions, independently of chloride channel inhibition.
Kelly M; Trudel S; Brouillard F; Bouillaud F; Colas J; Nguyen-Khoa T; Ollero M; Edelman A; Fritsch J
J Pharmacol Exp Ther; 2010 Apr; 333(1):60-9. PubMed ID: 20051483
[TBL] [Abstract][Full Text] [Related]
19. [Early bronchial inflammation in cystic fibrosis].
Puchelle E
J Soc Biol; 2002; 196(1):29-35. PubMed ID: 12134630
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
